Pinnacle 21 Attracts Clinical Data Standards Executive

PLYMOUTH MEETING, Pa., June 7, 2016 /PRNewswire/ -- Pinnacle 21, the leading provider of clinical data standards software and subject matter expertise to the life sciences industry, today announced that Tom Guinter has joined the company as vice president of clinical data services.

As vice president, clinical data services, Mr. Guinter is responsible for developing Pinnacle 21's clinical data standards-driven service offerings while also lending his expertise to the enhancement of the Pinnacle 21 Community and Enterprise suite of software tools.  

Mr. Guinter brings a wealth of industry experience to his new role. He previously worked as an independent consultant providing clinical data standards expertise to the industry's top clinical trial sponsors. In addition, he has held several leadership positions within sponsor and software vendor organizations, including GRMS Life Sciences, Take Solutions, Octagon Research Solutions and Sanofi.

Max Kanevsky, CEO, Pinnacle 21, commented, "Tom brings a unique combination of sponsor and vendor experience that is founded in a deep understanding of the use, best practices and benefits of implementing clinical data standards. His leadership experience and innovative approach to data standardization make him a great fit for the Pinnacle 21 team."

Tom Guinter, vice president, clinical data services, added, "I am really excited to join Pinnacle 21. Our team has developed the industry standard tool for validating and documenting CDISC clinical data for electronic regulatory submissions. The FDA and the PMDA are both using the tool. This positions us well to offer unprecedented, practice-based expertise to the market in the form of novel services that complement our suite of tools."

Mr. Guinter is located in Pinnacle 21's headquarters office in Plymouth Meeting, Pennsylvania.

About Pinnacle 21

Pinnacle 21 is the leading provider of clinical data standards software and subject matter expertise to the life sciences industry. The US FDA and Japanese PMDA leverage Pinnacle 21 Enterprise to validate and review clinical data submitted in electronic regulatory submissions according to the CDISC SDTM and ADaM standards. Learn more at www.pinnacle21.net.

Logo - http://photos.prnewswire.com/prnh/20160606/376074LOGO

SOURCE Pinnacle 21

Related Links

https://www.pinnacle21.net